Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
Open Access
- 1 January 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (2), 751-758
- https://doi.org/10.1074/jbc.m805000200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Thrombin Hydrolysis of Human Osteopontin Is Dependent on Thrombin Anion-binding ExositesJournal of Biological Chemistry, 2008
- SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26Frontiers in Bioscience-Landmark, 2008
- Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptorFrontiers in Bioscience-Landmark, 2008
- Heparin‐induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly/disassemblyJournal of Clinical Apheresis, 2007
- The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissuesBlood, 2007
- Platelet interaction with progenitor cells: Potential implications for regenerative medicineThrombosis and Haemostasis, 2007
- Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivoBlood, 2006
- Chemoattractants, extracellular proteases, and the integrated host defense responseExperimental Hematology, 2006
- Chemokine-like receptor 1 expression by macrophages in vivo: Regulation by TGF-β and TLR ligandsExperimental Hematology, 2006
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996